The effectiveness of unconventional monetary policy (“QE” for short) has been a subject of intense debate in both academic and policy circles. A significant part of QE research originates in central banks (Martin and Milas, 2012). Central banks evaluating their own policies is not unlike pharmaceutical firms evaluating their own drugs. Both have skin in the game.